Clinical Profile and Treatment Outcome of Aluminum Phosphide Poisoning in Felege Hiwot Referral Hospital, Northwest Ethiopia: A Retrospective Study

Figures & data

Figure 1 Percentage distribution of cases by age category.

Table 1 Observed Laboratory Results

Laboratory Test	n*	Mean (SD)	Range
WBC (10^3/mm^3)	43	8.2 (4.7)	1.6–23.9
Creatinine (mg/dl)	35	1.2 (0.8)	0.3–4.15
BUN (mg/dl)	24	30.7 (19.1)	8–69
SGOT (U/L)	20	67.1 (76.8)	8–293
SGPT (U/L)	20	51.6 (45.9)	10–191
Alkaline phosphatase, serum (U/L)	14	169.6 (59.8)	95–316
Sodium (mmol/L)	24	141.8 (6.1)	129.6–149.9
Potassium (mmol/L)	23	4.4 (0.9)	2.8–6
Chloride (mmol/L)	18	110.1 (8)	93–125

Note: * n is different for different tests because all these tests were not done uniformly in all 125 cases.

Abbreviations: n, number of patients tested for the respective laboratory test; SD, standard deviation.

Table 2 Sub-Group Analysis

Regimen with MgSo4, Ca Gluconate, IV Hydrocortisone & Dopamine	Hypotensive Group (SBP <90mmHg)					Non-Hypotensive Group
	Total Number	Patient Outcome			Mortality	Total Number	Patient Outcome			Mortality
		Improved	Expired	Went Against Medical Advice			Improved	Expired	Went Against Medical Advice
Treated with the above regimen	54	24	30	0	55.6%	0	-	-	-	-
Not treated with the above regimen	9	0	9	0	100%	62	54	0	8	0%
Total number/ percent	63	24	39	0	61.9%	62	54	0	8	0%